CytoGen Polska Sp. z oo was founded in 1996. It operates on the Polish market as a supplier of various reagents and small laboratory equipment. For many years, it has been cooperating with well-known producers all over the world and our offer is used by research centers and medical facilities, among others :
CytoGen Polska Sp. z .oo actively supports the majority of congresses and scientific conferences related to its profile. Skillfully follows the latest developments and trends in both the scientific and medical industries. It offers its recipients reliable information, assistance, substantive and technical support, access to the best and innovative products on the Polish market as well as free samples of selected products.
Ethics
In its activity, the company is primarily guided by the good of the client and adherence to the principle of fair competition.
We invite you to cooperation!
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.10.Z - Manufacture of basic pharmaceutical products
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,6 | 0,6 | 0,8 | 36 |
Gross profit (loss) | 0,6 | 0,6 | 0,8 | 50,1 |
EBITDA | 0,7 | 0,6 | 0,8 | 37,3 |
Short time liabilities | 0,6 | 0,7 | 0,5 | -19,3 |
Other operating costs | 0 | 0 | 0 | -57,1 |
Equity capital | 1,8 | 2,3 | 2,6 | 11,1 |
Operating profit (EBIT) | 0,6 | 0,6 | 0,8 | 40 |
Assets | 2,4 | 3 | 3,1 | 4,2 |
Net profit (loss) | 0,5 | 0,5 | 0,8 | 50,1 |
Cash | 1,3 | 1,7 | 1,8 | 9,5 |
Net income from sale | 3,6 | 3,7 | 4,1 | 11,3 |
Liabilities and provisions for liabilities | 0,6 | 0,7 | 0,5 | -19,3 |
Working assets | 2,1 | 2,7 | 2,9 | 6,1 |
Other income costs | 0,1 | 0 | 0 | -99,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 30,2 | 22,1 | 29,8 | 7,7 |
Equity capital to total assets | 74,3 | 77,3 | 82,5 | 5,2 |
Gross profit margin | 16,4 | 15,2 | 20,5 | 5,3 |
EBITDA Margin | 18,7 | 16,6 | 20,5 | 3,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 62 | 67 | 49 | -18 |
Current financial liquidity indicator | 3.4123387336730957 | 4.014916896820068 | 5.281982421875 | 1,3 |
Net dept to EBITDA | -1.9188748598098755 | -2.7164666652679443 | -2.1676974296569824 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane